HVNI for Pulmonary Hypertension

About Vapotherm

Vapotherm's mission is to improve patient outcomes and experiences in respiratory distress by commercializing its innovative High Velocity Therapy® platform. The company has achieved global commercial adoption of its Precision Flow® systems, establishing HVNI as a standard of care in many hospitals for conditions like respiratory failure and COPD exacerbation. Its strategy focuses on expanding clinical evidence, penetrating home care markets, and leveraging its versatile platform across new indications and care settings to drive growth.

Therapeutic Areas